Gastrointestinal Endoscopy
Volume 71, Issue 2 , Pages 260-265 , February 2010

Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA

Received 9 June 2009 ,Accepted 23 August 2009.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249
  2. DeWitt J, Devereaux BM, Lehman GA, et al. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol. 2006;4:717–725
  3. DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasound and multidetector computed tomography for the detection and staging of pancreatic cancer. Ann Intern Med. 2004;141:753–763
  4. Cardenes HR, Chiorean EG, DeWitt J, et al. Locoregionally advanced pancreatic cancer: current therapeutic approach. Oncologist. 2006;11:612–623
  5. DeWitt J, LeBlanc J, McHenry L, et al. Endoscopic ultrasound guided-fine needle aspiration cytology of solid liver lesions: a large single center experience. Am J Gastroenterol. 2003;98:1976–1981
  6. Hollerbach S, Willert J, Topalidis T, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy of liver lesions: histological and cytological assessment. Endoscopy. 2003;35:743–749
  7. DeWitt J, LeBlanc J, McHenry L, et al. Endoscopic ultrasound-guided fine needle aspiration of ascites. Clin Gastroenterol Hepatol. 2007;5:609–615
  8. Nguyen PT, Chang KJ. EUS in the detection of ascites and EUS guided paracentesis. Gastrointest Endosc. 2001;54:336–339
  9. Lee YT, Ng EK, Hung LC, et al. Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut. 2005;54:1541–1545
  10. Chu KM, Kwok KF, Law S, et al. A prospective evaluation of catheter probe EUS for the detection of ascites in patients with gastric carcinoma. Gastrointest Endosc. 2004;59:471–474
  11. Chen CH, Yang CC, Yeh YH. Preoperative staging of gastric cancer by endoscopic ultrasound: the prognostic usefulness of ascites detected by endoscopic ultrasound. J Clin Gastroenterol. 2002;35:321–327
  12. Nakata B, Nishino H, Ogawa Y, et al. Prognostic predictive value of endoscopic ultrasound findings for invasive ductal carcinomas of pancreatic head. Pancreas. 2005;30:200–205
  13. Chang KJ, Albers CG, Nguyen P. Endoscopic ultrasound-guided fine needle aspiration of pleural and ascitic fluid. Am J Gastroenterol. 1995;90:148–150
  14. Mariette C, Balon JM, Maunoury V, et al. Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma. Br J Surg. 2003;90:1367–1372
  15. Das A, Chak A, Sivak MV, et al. Endoscopic ultrasonography and prognosis of esophageal cancer. Clin Gastroenterol Hepatol. 2006;4:695–700
  16. Chen J, Xu R, Hunt GC, et al. Influence of the number of malignant regional lymph nodes detected by endoscopic ultrasonography on survival stratification in esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2006;4:573–579
  17. Twine CP, Barry JD, Blackshaw GR, et al. Prognostic significance of endoscopic ultrasound-defined pleural, pericardial or peritoneal fluid in oesophageal cancer. Surg Endosc. 2009;23:2229–2236
  18. Sultan J, Robinson S, Hayes N, et al. Endoscopic ultrasonography-detected low-volume ascites as a predictor of inoperability for oesophagogastric cancer. Br J Surg. 2008;95:1127–1130
  19. Giovannini M, Monges G, Seitz JF, et al. Distant lymph node metastases in esophageal cancer: impact of endoscopic ultrasound-guided biopsy. Endoscopy. 1999;31:536–540
  20. Eloubeidi MA, Wallace MB, Hoffman BJ, et al. Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: impact of staging endosonography. Ann Thorac Surg. 2001;72:212–220
  21. Harewood GC, Wiersema MJ, Nelson H, et al. A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. Gastroenterology. 2002;123:24–32
  22. Glancy DG, Pullyblank AM, Thomas MG. The role of colonoscopic endoanal ultrasound scanning (EUS) in selecting patients suitable for resection by transanal endoscopic microsurgery (TEM). Colorectal Dis. 2005;7:148–150
  23. Agarwal B, Correa AM, Ho L. Survival in pancreatic carcinoma based on tumor size. Pancreas. 2008;36:e15–e20
  24. Erickson RA, Garza AA. Impact of endoscopic ultrasound on the management and outcome of pancreatic carcinoma. Am J Gastroenterol. 2000;95:2248–2254
  25. Evans DB, Abbruzzese JL, Willett CG. Cancer of the pancreas. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Cancer: principles and practice of oncology. 6th ed. Philadelphia (PA): Lippincott-Raven; 2001;p. 1126–1161
  26. Hawes RH, Xiong Q, Waxman I, et al. A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol. 2000;95:17–31
  27. Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc. 1998;47:1–7
  28. Knyrim K, Wagner HJ, Pausch J, et al. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy. 1993;25:207–212
  29. Kaassis M, Boyer J, Dumas R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003;57:178–182
  30. Davids PH, Groen AK, Rauws EA, et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340:1488–1492
  31. Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc. 2006;63:986–995
  32. Levy MJ, Baron TH, Gostout CJ, et al. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence based approach. Clin Gastroenterol Hepatol. 2004;2:273–285
  33. Arguedas MR, Heudebert GH, Stinnett AA, et al. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis. Am J Gastroenterol. 2002;97:898–904
  34. Yeoh KG, Zimmerman MJ, Cunningham JT, et al. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc. 1999;49:466–471
  35. Fung MC, Takayama S, Ishiguro H, et al. Chemotherapy for advanced or metastatic pancreatic cancer: analysis of 43 randomized trials in 3 decades (1974-2002). Gan To Kagaku Ryoho. 2003;30:1101–1111
  36. Nieto J, Grossbard ML, Kozuch P. Metastatic pancreatic cancer 2008: is the glass less empty?. Oncologist. 2008;13:562–576
  37. Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403–2413

 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.

 See CME section; p. 365

 If you would like to chat with an author of this article, you may contact Dr. DeWitt at jodewitt@iupui.edu.

PII: S0016-5107(09)02425-0

doi: 10.1016/j.gie.2009.08.025

Gastrointestinal Endoscopy
Volume 71, Issue 2 , Pages 260-265 , February 2010

Article Tools

* Image Usage & Resolution